Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.12. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
04.12. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
25.11. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
24.10. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
09.10. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
16.09. | IINN Stock Gains on Second US Patent Approval for VORTX System | 2 | Zacks | ||
13.09. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
23.08. | INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare | 1 | Zacks | ||
22.08. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
22.08. | Inspira Technologies Announces FDA Listing and Market Readiness of New Product | 120 | PR Newswire | RA'ANANA, Israel, Aug. 22, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation... ► Artikel lesen | |
13.08. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
30.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
11.07. | Inspira Technologies Gets Israeli Ministry Of Health Approval For INSPIRA ART100 ECMO System | 1 | RTTNews | ||
11.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
20.06. | Inspira Technologies: Inspira Announces Business Plan Targets | 133 | PR Newswire | Company to aggressively promote INSPIRA ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA ART (Gen2)
RA'ANANA, Israel, June... ► Artikel lesen | |
25.03. | Inspira Technologies Reports Full Year 2023 Financial Results | 187 | PR Newswire | FDA Submission for approval of INSPIRA ART100
95% Accuracy Results for HYLA Blood Sensor Compared to Standard Blood Gas Analyzers
Granted U.S. Patent for INSPIRA ART Medical Device
RA'ANANA, Israel... ► Artikel lesen | |
27.02. | Inspira Technologies: Inspira Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements | 258 | PR Newswire | RA'ANANA, Israel, Feb. 27, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company... ► Artikel lesen | |
14.02. | Inspira Technologies: Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System | 342 | PR Newswire | 94% of the Claims Were Found to be Novel
RA'ANANA, Israel, Feb. 14, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies")... ► Artikel lesen | |
09.01. | Inspira Technologies: Inspira Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity | 193 | PR Newswire | The kit is being designed for the INSPIRA ART device series and is intended to be compatible with various life support machines sold in the market
RA'ANANA, Israel, Jan. 9, 2024 /PRNewswire/ -- Inspira... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AVINGER | 1,380 | +114,82 % | Avinger Inc - 8-K, Current Report | ||
PROCEPT BIOROBOTICS | 83,46 | +2,85 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GENEDX | 76,75 | +0,46 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
NANO-X IMAGING | 7,015 | -0,78 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
RXSIGHT | 34,305 | -0,82 % | RxSight cut to hold at Stifel on competition concerns | ||
EUROPEAN WAX CENTER | 5,405 | +4,95 % | European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results | Reiterates fiscal 2024 financial outlook Updates fiscal 2024 outlook for net new centers Third Quarter Fiscal 2024 versus 2023 Net new centers increased 3.7% to 1,064 total centers in 45 statesSystem-wide... ► Artikel lesen | |
908 DEVICES | 1,880 | -1,05 % | 908 Devices stock hits 52-week low at $1.82 amidst market challenges | ||
CASTLE BIOSCIENCES | 27,490 | +0,04 % | Castle Biosciences plant Markteinführung von Neurodermitis-Test bis Ende 2025 | ||
CVRX | 12,835 | +2,68 % | CVRx, Inc.: CVRx Reports Third Quarter 2024 Financial and Operating Results | MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
TALKSPACE | 3,040 | +1,33 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
CLEARPOINT NEURO | 15,620 | +6,77 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen | |
WORK MEDICAL TECHNOLOGY GROUP | 4,670 | -5,08 % | WORK Medical Technology Group LTD - F-1, Registration statement for certain foreign private issuers | ||
ALIGNMENT HEALTHCARE | 10,610 | -0,93 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
PROGYNY | 14,480 | -0,07 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
ADAPTHEALTH | 10,070 | -0,98 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |